
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q1 2025 Earnings Call Transcript
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q1 2025 Earnings Call Transcript May 13, 2025 Capricor Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.53 EPS, expectations were $-0.33. Operator: Good afternoon, ladies and gentlemen, and …